Handelsbanken Fonder AB Buys 339,020 Shares of UnitedHealth Group Incorporated $UNH
by Mitch Edgeman · The Markets DailyHandelsbanken Fonder AB lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 97.3% in the 2nd quarter, Holdings Channel reports. The fund owned 687,561 shares of the healthcare conglomerate’s stock after acquiring an additional 339,020 shares during the quarter. UnitedHealth Group accounts for 0.8% of Handelsbanken Fonder AB’s holdings, making the stock its 18th biggest holding. Handelsbanken Fonder AB’s holdings in UnitedHealth Group were worth $285,771,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in UNH. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group during the 4th quarter valued at about $25,000. Anfield Capital Management LLC increased its stake in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $27,000. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in UnitedHealth Group in the fourth quarter worth $29,000. Institutional investors own 87.86% of the company’s stock.
Insider Transactions at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 500 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the sale, the chief executive officer directly owned 16,497 shares in the company, valued at approximately $6,763,770. The trade was a 2.94% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.19% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts have recently issued reports on UNH shares. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target for the company in a research report on Wednesday, April 22nd. Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday. HSBC increased their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a report on Monday, July 6th. Mizuho upped their price objective on UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a research report on Monday, July 20th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $455.92.
View Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Trading Up 0.4%
NYSE:UNH opened at $408.70 on Tuesday. The company has a 50 day simple moving average of $414.66 and a two-hundred day simple moving average of $351.47. The company has a market cap of $371.16 billion, a PE ratio of 26.30, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a 12 month low of $252.14 and a 12 month high of $461.62.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period last year, the business posted $4.08 EPS. The company’s revenue for the quarter was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were paid a $2.32 dividend. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 59.72%.
About UnitedHealth Group
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).